Fc glycan-modulated immunoglobulin G effector functions

Area of Science:

• Glycoscience
• Immunology
• Biochemistry

Background:

• Immunoglobulin G (IgG) molecules are glycoproteins with essential N-linked glycans on the Fc region.
• These glycans influence IgG effector functions, including Fc receptor binding and complement activation.
• The core glycan structure comprises mannose and N-acetylglucosamine, with terminal modifications like sialic acid and fucose.

Purpose of the Study:

• To review recent advances in understanding the role of IgG-Fc glycans in immune responses.
• To highlight the significance of specific glycan residues, particularly sialic acid and fucose, for IgG functionality.
• To discuss the implications of IgG glycosylation for immunotherapy, focusing on intravenous immunoglobulin (IVIG) treatment.

Main Methods:

• Literature review of recent research on IgG glycosylation and its functional impact.
• Analysis of studies investigating the influence of specific glycan residues (sialic acid, fucose) on IgG activity.
• Examination of data related to the therapeutic applications of IgG glycosylation modulation, including IVIG.

Main Results:

• IgG-Fc glycan composition significantly impacts pro- and anti-inflammatory activities.
• Sialic acid and fucose residues are critical determinants of IgG's immunomodulatory properties.
• Variations in IgG glycosylation can be therapeutically exploited for immune modulation.

Conclusions:

• IgG glycosylation is a crucial factor in immune system regulation.
• Targeting specific glycan residues offers potential for novel immunotherapeutic strategies.
• Further research into IgG-Fc glycosylation, especially concerning sialic acid and IVIG, is vital for advancing immunotherapy.